Business / Finance

RSS

Human Longevity announces acquisition of Cypher Genomics

Human Longevity, Inc., the genomics-based, technology-driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions.

30 Nov 2015

SuperCom awarded $8 million in new contracts

SuperCom Ltd., a leading provider of secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors, today announced that it has been awarded new contracts, totaling approximately $8 million. The Company expects to deliver and recognize the full value of the orders during the first half of 2016.

30 Nov 2015

Heptares announces strategic drug discovery collaboration with Pfizer

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.

30 Nov 2015

Mallinckrodt sells CMDS business to Guerbet for $270 million

Mallinckrodt plc, a leading specialty biopharmaceutical company, announced today that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million.

28 Nov 2015

Lannett acquires Kremers Urban Pharmaceuticals from UCB for $1.23 billion

Lannett Company, Inc. today announced that it has completed the acquisition of Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A.

27 Nov 2015

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the nine months ended September 30, 2015 and updates on its drug development programs.

27 Nov 2015

TSO3, Getinge Infection Control ink global distributor agreement for STERIZONE VP4 Sterilizer

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, has granted Getinge Infection Control AB, a global leader in infection control solutions, exclusive global distributor rights to its FDA-cleared, STERIZONE VP4 Sterilizer for US$7.5 million, plus performance minimums

25 Nov 2015

BioLight signs joint financing agreement with two Asia-based venture capital firms

BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.

25 Nov 2015

BioPlast Manufacturing acquires Kord-Valmark

BioPlast Manufacturing, a manufacturer of plastic components used primarily for the medical research, clinical diagnostic and biotech environments, announced today that it has acquired Kord-Valmark, a leading manufacturer of quality petri dishes. This acquisition is aligned with BioPlast Manufacturing's strategy to offer clients a platform of products that are designed and tested by scientists for scientists and manufactured with the highest quality.

24 Nov 2015

TeamHealth successfully completes acquisition of IPC Healthcare

Team Health Holdings, Inc., a leading physician services organization, today announced it has successfully completed its acquisition of IPC Healthcare, Inc., a national acute hospitalist and post-acute provider organization.

23 Nov 2015

ProMetic, ProThera form strategic partnership to develop and commercialize Inter-alpha Inhibitor Proteins

ProMetic Life Sciences Inc. announced today that it has entered into a strategic partnership with ProThera Biologics Inc. for the development and commercialization of human plasma-derived Inter-alpha Inhibitor Proteins.

19 Nov 2015

Cell Therapy Catapult initiates construction for cell and gene therapy manufacturing centre

The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre.

18 Nov 2015

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended September 30, 2015.

17 Nov 2015

Corning signs agreement to become global distributor for popular BioCision products

Corning Incorporated and BioCision, LLC today announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.

17 Nov 2015

ALPHAEON signs agreement with PhysIOL to develop and commercialize Trifocal lens technology

ALPHAEON Corporation today announced it has entered into a definitive agreement with PhysIOL SA of Belgium, to jointly develop and commercialize an exclusive ALPHAEON-branded Trifocal lens technology. Specific terms of the agreement were not disclosed.

15 Nov 2015

DePuy offers ambulatory surgery outpatient solutions for joint replacement patients

DePuy Synthes Companies announces the national launch of the DEPUY SYNTHES ADVANTAGE™ Outpatient Solutions Program to facilitate best practices and protocols for joint replacement in ambulatory surgical centers (ASCs) and outpatient hospitals throughout the United States.

13 Nov 2015

CASI reports net loss of $1.6 million for third quarter 2015

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, today reported financial results for the three and nine months ended September 30, 2015.

13 Nov 2015

Natera's total revenues decrease 2.9% to $44.9 million in third quarter 2015

Natera, Inc., a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the third quarter ended September 30, 2015 and provided an update on recent business progress.

From Natera 13 Nov 2015

Baylor Miraca Genetics Laboratories licenses SNP probe technology from OGT

Oxford Gene Technology (OGT), The Molecular Genetics Company, has entered into a deal with Baylor Miraca Genetics Laboratories (BMGL), licensing the use of OGT’s proprietary single nucleotide polymorphism (SNP) array probe technology.

From Oxford Gene Technology 12 Nov 2015

Hospice Pharmacy Solutions Completes Merger With Outcome Resources

Hospice Pharmacy Solutions, a Dallas-based pharmacy benefit management service (PBM), announced Monday that it has merged Sacramento-based hospice PBM Outcome Resources into its operations. The announcement was made jointly by Mike Nault, CEO of Hospice Pharmacy Solutions, and Jack Sayler, president of Outcome Resources.

12 Nov 2015

Business / Finance

Human Longevity announces acquisition of Cypher Genomics

SuperCom awarded $8 million in new contracts

Heptares announces strategic drug discovery collaboration with Pfizer

Mallinckrodt sells CMDS business to Guerbet for $270 million

Lannett acquires Kremers Urban Pharmaceuticals from UCB for $1.23 billion

Can-Fite BioPharma reports financial results, provides updates on drug development programs

TSO3, Getinge Infection Control ink global distributor agreement for STERIZONE VP4 Sterilizer

BioLight signs joint financing agreement with two Asia-based venture capital firms

BioPlast Manufacturing acquires Kord-Valmark

TeamHealth successfully completes acquisition of IPC Healthcare

ProMetic, ProThera form strategic partnership to develop and commercialize Inter-alpha Inhibitor Proteins

Cell Therapy Catapult initiates construction for cell and gene therapy manufacturing centre

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

Corning signs agreement to become global distributor for popular BioCision products

ALPHAEON signs agreement with PhysIOL to develop and commercialize Trifocal lens technology

DePuy offers ambulatory surgery outpatient solutions for joint replacement patients

CASI reports net loss of $1.6 million for third quarter 2015

Natera's total revenues decrease 2.9% to $44.9 million in third quarter 2015

Baylor Miraca Genetics Laboratories licenses SNP probe technology from OGT

Hospice Pharmacy Solutions Completes Merger With Outcome Resources

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News